September 17, 2024

Anne brings over 25 years of global experience in Life Sciences, Healthcare, and Cell Therapy. She is currently the President and CEO of G-CON Manufacturing, Inc., and has held senior roles at Celularity Inc. and Genuity Science. Anne has also driven business growth at Danaher Corporation, Agilent Technologies, and GE Healthcare. She holds a PhD in Cancer Research. CEO Ruizhi Wang believes Anne’s expertise will be crucial for Abselion’s commercial growth and innovation in protein quantification technology. Anne is excited to support Abselion’s innovative and impactful technology.

August 20, 2024

Collaborative Project to Develop Next-Generation Cell Platform for Viral Vector Production Receives £1.1 Million Grant from Innovate UK & NRC

December 8, 2023

Abselion recently attended the BIA bioprocess 2023 conference and presented our Amperia platform in the “dragons den” session for next generation analytics.

August 4, 2023

The last few years have been nothing short of amazing – together, we have achieved remarkable milestones that we can all be incredibly proud of. From winning countless awards to securing investments, building an exceptional product, and showcasing our outstanding performance, we have left an indelible mark on the biotech industry.

October 20, 2021

At ELRIG Drug Discovery 2021, HexagonFab received the Innovation AveNEW top startup company award from SLAS!

July 2, 2021

When Abselion was founded in 2018 (at that time under the name HexagonFab), we did not set out to change the world. What we set out to do instead is to create tools that empower scientists to do research faster and easier than ever before. We want to free our users from tedious tasks and to give them back their time to be creative, to follow their passion and to pursue new ideas. We want them to discover more. In a way, we help them to change the world.​

April 20, 2021

HexagonFab today announces a £1.9 million (CHF 2.5 million) seed funding round, led by Cambridge Enterprise, joined by Parkwalk, New Grounds VC, Silicon Valley based R42 Group, Swiss Health Angels and several private investors.

February 5, 2020

Last week we presented our solution for next generation medical sensing to a panel of experts at AMS, a world-leader in automotive, wearable and medical sensing.

July 1, 2019

Dr. Ruizhi Wang has been awarded a Royal Academy of Engineering Enterprise Fellowship

October 1, 2018

The focus of the event was the Royal Society of Chemistry Emerging Technologies Competition final, in which 39 candidates – from a mixture of start-ups, SMEs and university research spin-outs – pitched their ideas to panels of experts in a ‘Dragon’s Den’ style competition.

June 12, 2018

HexagonFab wins Merck's Displaying Futures Award 2018